Skip to content
Medical Health Aged Care, Women

Monash Expert: SPHERE NHMRC Centre of Research Excellence federal budget response

Monash University 2 mins read

The federal government’s 2024-25 budget was released last night, with some emphasis on women’s health. 

 

The following can be attributed to Director of SPHERE, Professor Danielle Mazza AM. SPHERE is the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Women’s Sexual and Reproductive Health in Primary Care.

 

Professor Mazza is not available for further comment.

 

The 2024-2025 budget brings welcome news for women’s health, with a broad spectrum of initiatives addressing a range of health conditions including endometriosis, miscarriage, preterm birth, breast cancer and menopause. There is good news too for women’s sexual and reproductive health, particularly in the areas of contraception and abortion. 

 

“Most welcome is the announcement that the sexual and reproductive health telehealth Medicare item numbers introduced during the COVID-19 pandemic to support remote access to essential women’s health services, such as abortion, are to be made permanent. 

 

“Access to abortion will also benefit through budget measures supporting nurse practitioners. Some $5.7 million goes to new 60 minute Medicare Benefits Schedule (MBS) item numbers to support nurse practitioners and their requests for ultrasound scanning. Ultrasounds are commonly required when providing medical abortion care and this initiative will support nurse practitioners to deliver abortion services. This update is in line with the Therapeutic Goods Administration changes last year which authorised nurse practitioners to prescribe abortion medicine MS-2 Step.

 

“Workforce capacity development is another focus of the women’s health budget. A scholarship fund of $5.2 million dollars will be made available to support primary care health professionals undertake training in the insertion of intrauterine devices. The scholarships will support travel, accommodation and course costs, and will be of particular assistance to those working in rural and regional areas. There is also the promise of an MBS review in relation to item numbers for insertion and removal of long acting reversible contraceptives. Increased rebates may encourage more GPs to deliver these services and ensure improved access.  

 

"Other important sexual and reproductive health-focused initiatives include:

  • $1.1 million for the development of a virtual contraceptive decision-making tool to help women better understand their contraceptive options.
  • $5.5 million to support for the Australian Institute of Health and Welfare to develop a new dataset on sexual and reproductive health to give a better picture of what services are being delivered, and where there is unmet need.

“Assistant Minister Kearney is to be congratulated for introducing these initiatives and others that are aligned to the National Women's Health Advisory Council’s four areas of focus: Access, Care and Outcomes, Empowerment, Safety and Research. 

“While many of the SPHERE Coalition’s recommendations to the Senate Inquiry into universal access to reproductive health are being implemented in the Budget, the most significant one, the recommendation to provide free contraception and abortion services to Australian women, has not. Affordability of these services will need to be a focus of the government moving forwards if Australian women are truly to have universal access to essential women’s health services.”

For more information regarding SPHERE's recommendations to the government, please visit, https://www.spherecre.org/our-impact/coalition/consensus-statements

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected]

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.